Contacts. For Merz Pharma Group: Ute Weinhold, + 49-69-15 03-889 Head of Corporate Communications or Joele Frank, Wilkinson Brimmer Katcher Steve Frankel / Jim Shaughnessy, +1-212-355-4449 ...

Merz North America announced today it has expanded its aesthetic portfolio through the acquisition of ON Light Sciences, Inc. – a U.S. medical device ...

Nasdaq listed medical aesthetics company, BioForm Medical, Inc (BFRM) announced that its Board of Directors had unanimously accepted a cash offer of US$5.45 per share from German pharmaceutical ...

Merz Aesthetics Announces FDA Approval of Asclera(TM) (Polidocanol) Injection, First Sclerosant to Treat Small Varicose Veins in 60 Years Saturday, April 24, 2010 General News Advertisement ...

Merz will start operating in the new structure January 1, 2020. Rhatigan said he plans to make new hires shortly. “It will definitely be a net increase, and particularly at a senior level.

Merz North America is a specialty health care company in Greensboro that develops and commercializes treatments in aesthetics, dermatology and neurosciences in the U.S. and Canada. Merz Pharma ...

German aesthetic player Merz has invested in recently announced company Cytrellis Biosystems. The Boston-based startup is developing aesthetic medical devices to remove sagging skin without ...

Nasdaq listed medical aesthetics company, BioForm Medical, Inc (BFRM) announced that its Board of Directors had unanimously accepted a cash offer of US$5.45 per share from German pharmaceutical ...